Cargando…
Potential markers for sample size estimations in hereditary spastic paraplegia type 5
BACKGROUND: Aim to identify potential biomarkers to assess therapeutic efficacy for hereditary spastic paraplegias type 5 (SPG5) by investigating the clinical, cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI) features. METHODS: We performed a cross-sectional study to compare SPG5 patie...
Autores principales: | Lin, Qianqian, Liu, Ying, Ye, Zhixian, Hu, Jianping, Cai, Wenjie, Weng, Qiang, Chen, Wan-Jin, Wang, Ning, Cao, Dairong, Lin, Yi, Fu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451094/ https://www.ncbi.nlm.nih.gov/pubmed/34538260 http://dx.doi.org/10.1186/s13023-021-02014-w |
Ejemplares similares
-
Correction to: Potential markers for sample size estimations in hereditary spastic paraplegia type 5
por: Lin, Qianqian, et al.
Publicado: (2021) -
Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China
por: Dong, En-Lin, et al.
Publicado: (2018) -
Hereditary Spastic Paraplegia: An Update
por: Meyyazhagan, Arun, et al.
Publicado: (2022) -
Lipids in the Physiopathology of Hereditary Spastic Paraplegias
por: Darios, Frédéric, et al.
Publicado: (2020) -
Movement disorders in hereditary spastic paraplegias
por: Pedroso, Jose Luiz, et al.
Publicado: (2023)